To keep you up to date with the latest developments in virus bioinformatics, especially new tools that might help you in your research, the European Virus Bioinformatics Center is organising a regular lecture series entitled viruses in silico.
The lectures will usually take place on the last Thursday of the month at 4 pm CET/CEST | 10 am EST/EDT | 7 am PST/PDT.
The lectures take place online via Zoom – Use the registration form below to receive the login details (registration is possible until 1 hour before the start of the event). Registration is only necessary once, you will then receive updates about all upcoming speakers (you can unsubscribe at any time).
Please note that the lectures are not recorded. Exceptions can be requested in advance – please contact us beforehand.
Upcoming lectures
30 October 2025 | 4 pm CET
Sebastian Böcker (Friedrich Schiller University Jena, Germany)
SIRIUS and beyond: Turning tandem mass spectra into metabolite structure information
Liquid Chromatography Mass Spectrometry is a highly sensitive experimental platform for the analysis of metabolites and other small molecules. Unfortunately, structural elucidation of metabolites from tandem MS data remains highly challenging; in untargeted metabolomics experiments, only a small percentage of spectra can be annotated via spectral libraries. For more than a decade, my group has been developing computational solutions for this task. In my talk, I will explain CSI:FingerID searches a query MS/MS spectrum in a molecular structure database; how CANOPUS assigns thousands of compound classes to a query spectrum, even when the compound is missing from all structural and spectral databases; and, how COSMIC assigns confidence to database search results. I will then describe new features of SIRIUS 6, such as the integration of MSNovelist for de novo structure elucidation, and Epimetheus for combinatorial fragmentation and validation of results. In the last part of my talk, I will show how our tools can be applied in virus research in the future, targeting oxylipins and cyclic oligonucleotides.
27 November 2025 | 4 pm CET
Emma Hodcroft (Swiss Tropical and Public Health Institute, Switzerland)
(Title TBA)